drugset / Trial / NCT00269087
GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study evaluates the safety of medicine on COPD (Chronic Obstructive Pulmonary Disease). This study will last up to 56 weeks, and subjects will visit the clinic 16 times. Subjects will be given breathing tests, and will record their breathing symptoms daily on diary cards.
Timeline
- Start
- 2005-01-28
- Primary completion
- 2006-10-01
- Completion
- 2006-10-25
Publications
- Background This study has not been published in the scientific literature.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fluticasone propionate/salmeterol | Unknown | 50 ug | — |
| Subject | fluticasone propionate/salmeterol | Unknown | 500 ug | — |